Showing 2841-2850 of 10619 results for "".
Amyloid-Targeted Therapies: A New Era in Alzheimer’s Disease Treatment
https://reachmd.com/programs/neurofrontiers/amyloid-targeted-therapies-a-new-era-in-alzheimers-disease-treatment/29278/Explore the latest amyloid-targeted therapies and how they might lead to a multifaceted treatment approach for Alzheimer's disease.Beyond the Brain Scan: Blood-Based Biomarker Tests for Alzheimer’s Detection
https://reachmd.com/programs/neurofrontiers/beyond-the-brain-scan-blood-based-biomarker-tests-for-alzheimers-detection/29093/Tune in to learn how blood-based biomarker tests are being used to detect Alzheimer's disease.Noah Worcester 2024: Dr. Bhatia on Actinic Keratosis
https://reachmd.com/conferences/noah-worcester-2024/noah-worcester-2024-dr-bhatia-actinic-keratosis/24585/Neal Bhatia, MD, FAAD, summarizes his lecture on actinic keratosis and photodynamic therapy at the 2024 Noah Worcester Dermatological Society meeting.Maternal Stroke: Causes, Risks, and Care in Pregnancy and Postpartum
https://reachmd.com/programs/neurofrontiers/maternal-stroke-causes-risks-and-care-in-pregnancy-and-postpartum/24089/Tune in to learn more about the causes, risks, and treatment of stroke in pregnancy and postpartum.Time for a Heart-to-Heart: Reflections of Life on the Transplant List
https://reachmd.com/programs/book-club/time-heart-heart-reflections-life-transplant-list/10069/Bob Mitchell recounts his story of survival when faced with significant heart disease and undergoing multiple organ transplants.What Does It Mean to Be Rich?
https://reachmd.com/programs/your-money-your-life-financial-advice-for-physicians/what-does-it-mean-be-rich/8135/Who is really rich? It is probably not who you think. Join Jim Hemphill, CERTIFIED FINANCIAL PLANNER™ and co-founder of TGS Financial Advisors, as he discusses the benefits of adopting a more practical and functional definition of wealth. Click here to learn more about other financial related prograNavigating Treatment Decisions for Rheumatoid Arthritis: Key Factors to Consider
https://reachmd.com/programs/living-rheum/navigating-treatment-decisions-for-rheumatoid-arthritis-key-factors-to-consider/15208/Rheumatoid arthritis treatment isn’t one-size-fits-all. Learn how clinical data, biases, and patient needs can inform decision-making.U.S. Preventive Services Task Force Updates Recommendations for Depression Screening in Adults
https://reachmd.com/programs/the-jama-report/us-preventive-services-task-force-updates-recommendations-depression-screening-adults/7900/[Read the Article] Depression is a common clinical problem, and is a leading cause of disability in adults. This condition is often under recognized and under treated, affecting individuals, families, businesses and society. The U.S. Preventive Services Task Force is an independent group of medicalBig Data in Quality Improvement: The Clinician's Role
https://reachmd.com/programs/lifelong-learning/big-data-in-quality-improvement-the-clinicians-role/7196/Host Alicia Sutton welcomes Dr. Arif Kamal, Director of Quality and Outcomes at the Duke Cancer Institute, to talk about ways in which clinicians can become more involved or even take the reins of leadership in quality improvement initiatives within their health systems. The discussion pays close atVenetoclax and Palbociclib in AML: Exploring New Findings
https://reachmd.com/programs/on-the-frontlines-of-amlall/venetoclax-palbociclib-aml-findings/56352/Despite recent treatment advances, most patients with acute myeloid leukemia (AML)—especially those ineligible for intensive chemotherapy—ultimately relapse due to adaptive resistance to therapies like venetoclax. Ryan Quigley is joined by Dr. Jeffrey Tyner and Dr. Melissa Stewart to explore